Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians' Education Resource®, LLC designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 1.5 Contact Hours.
The Miami Breast Cancer Conference®: Attendee Tumor Board is an exciting supplemental activity of the annual Miami Breast Cancer Conference that extends the case-based based format of the live Conference to a live-streamed, interactive webcast led by world-renowned breast cancer experts Patrick Borgen, MD; Elizabeth Mittendorf, MD, PhD; Hope Rugo, MD; and Debu Tripathy, MD.
Since 1982, the Miami Breast Cancer Conference® has radically transformed the ability of physicians and healthcare professionals to provide world-class care for their patients through engaging and practice-changing educational programming that provides up-to-the-minute advances in breast cancer oncology. It is engineered to pass expert perspectives on late-breaking research findings, controversies, and other breakthroughs to our attendees. Following 35 years of such innovation and leadership, Miami Breast continues to revolutionize the field of breast cancer education. Supplemental activities such as these are designed to provide essential updates so that practitioners can maintain state-of-the-art care for their patients year-round.
The Miami Breast Cancer Conference®: Attendee Tumor Board will bring conference-caliber education to the convenience of your screen!
This educational activity is directed toward medical oncologists, surgical oncologists, and radiation oncologists involved in the treatment and management of patients with breast cancer. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of breast cancer may also participate
Overview the design and endpoints of significant clinical trial studies that are focused on evaluating novel strategies in breast cancer treatment and management
Evaluate emerging data and novel strategies under investigation in the treatment of breast cancer
Discuss how emerging evidence regarding novel agents and evolving strategies can be placed into practice for the treatment of patients with breast cancer
Patrick I. Borgen, MD
Chair, Department of Surgery
Maimonides Medical Center
You must be logged in to PER to register for this meeting